Literature DB >> 17396106

Treatment of chronic pain in pediatric rheumatic disease.

Yukiko Kimura1, Gary A Walco.   

Abstract

Pain in children with rheumatic disease is common, and is most often caused by arthritis. Despite the widespread use of effective new biologic agents, pain continues to be a problem in these patients, and it greatly impairs their daily functioning and quality of life. The pathogenesis of pain in children with rheumatic diseases is multifactorial, and disease treatment alone is often not enough to alleviate it. No standard of care or detailed algorithm for managing pain in these patients exists. Specific pain treatments often include acetaminophen, NSAIDs and medications that treat arthritis, such as methotrexate and etanercept. Other approaches should include nonpharmacologic interventions, for example exercise and cognitive-behavioral therapy, as well as the use of analgesics such as opioids in patients whose pain is refractory to standard therapies. The use of systemic corticosteroids to treat pain in children with arthritis should be avoided.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17396106     DOI: 10.1038/ncprheum0458

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN: 1745-8382


  15 in total

Review 1.  Assessment and management of pain in juvenile idiopathic arthritis.

Authors:  Jennifer E Weiss; Nadia J C Luca; Alexis Boneparth; Jennifer Stinson
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

2.  Paediatric rheumatology: Juvenile idiopathic arthritis--are biologic agents effective for pain?

Authors:  Alessandro Consolaro; Angelo Ravelli
Journal:  Nat Rev Rheumatol       Date:  2013-07-02       Impact factor: 20.543

Review 3.  Assessment and management of pain in juvenile idiopathic arthritis.

Authors:  Jennifer N Stinson; Nadia J C Luca; Lindsay A Jibb
Journal:  Pain Res Manag       Date:  2012 Nov-Dec       Impact factor: 3.037

4.  Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.

Authors:  Huijing Wang; Cobi J Heijnen; Cindy T J van Velthoven; Hanneke L D M Willemen; Yoshihiro Ishikawa; Xinna Zhang; Anil K Sood; Anne Vroon; Niels Eijkelkamp; Annemieke Kavelaars
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

Review 5.  Neural mechanisms underlying the pain of juvenile idiopathic arthritis.

Authors:  Luke La Hausse de Lalouvière; Yiannis Ioannou; Maria Fitzgerald
Journal:  Nat Rev Rheumatol       Date:  2014-02-04       Impact factor: 20.543

Review 6.  Nonpharmacological treatment of pain in rheumatic diseases and other musculoskeletal pain conditions.

Authors:  Natoshia Raishevich Cunningham; Susmita Kashikar-Zuck
Journal:  Curr Rheumatol Rep       Date:  2013-02       Impact factor: 4.592

7.  Time to share.

Authors:  Nico M Wulffraat; Bas Vastert
Journal:  Pediatr Rheumatol Online J       Date:  2013-02-15       Impact factor: 3.054

8.  Muscle strength, physical fitness and well-being in children and adolescents with juvenile idiopathic arthritis and the effect of an exercise programme: a randomized controlled trial.

Authors:  Eva Sandstedt; Anders Fasth; Meta Nyström Eek; Eva Beckung
Journal:  Pediatr Rheumatol Online J       Date:  2013-02-22       Impact factor: 3.054

9.  Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment.

Authors:  Johanne Jeppesen Lomholt; Mikael Thastum; Troels Herlin
Journal:  Pediatr Rheumatol Online J       Date:  2013-05-06       Impact factor: 3.054

10.  Review of oral oxymorphone in the management of pain.

Authors:  Paul Sloan
Journal:  Ther Clin Risk Manag       Date:  2008-08       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.